InsidersTradesSigma
Track the Iovance Biotherapeutics, INC. stock price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, Iovance Biotherapeutics, INC. has logged 114 insider filings. Market capitalisation: €3.6bn. The latest transaction was filed on 3 September 2026 (Levée d'options). Among the most active insiders: BILINSKY IGOR. The full history is free.
114
Insider Decl.
n/a
Thresholds
€135m
19 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Iovance Biotherapeutics, INC. Buy (bullish), based on 9 analysts. Average price target: US$10.00.
35Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,037 of 29,062 companies
22.3
score / 100
Value16
Quality28
FCF yld-9.3%
Earn yld-11%
EV/EBITDA·
ROE-40%
Gross mgn34%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 September 2026
Declarations114 total
8,789 shares0Common StockSEC:0001104659-26-105099:0
4,472 shares@ US$8.28Common StockSEC:0001104659-26-105099:1
5,470 shares0Common StockSEC:0001104659-26-105100:0
2,508 shares@ US$8.28Common StockSEC:0001104659-26-105100:1
41,669 shares0Common StockSEC:0001104659-26-105101:0
17,702 shares@ US$8.28Common StockSEC:0001104659-26-105101:1
2,436 shares@ US$6.400.0004% mcap21.9% of flowCommon StockSEC:0001104659-26-095040:1
10,001 shares0Common StockSEC:0001104659-26-095040:0
21,238 shares@ US$6.210.0037% mcap100.0% of flowCommon StockSEC:0001104659-26-093482:1
49,995 shares0Common StockSEC:0001104659-26-093482:0
7,813 shares0Common StockSEC:0001104659-26-071891:0
7,813 shares0Common StockSEC:0001104659-26-071897:0
3,976 shares@ US$4.230.0005% mcap39.3% of flowCommon StockSEC:0001104659-26-071891:1
3,976 shares@ US$4.230.0005% mcap100.0% of flowCommon StockSEC:0001104659-26-071897:1
4,473 shares@ US$3.9668.2% of flowCommon StockSEC:0001104659-26-070149:1
8,790 shares0Common StockSEC:0001104659-26-070149:0
62,493 shares0Common StockSEC:0001104659-26-024765:0
31,246 shares0Common StockSEC:0001104659-26-024762:0
39,059 shares0Common StockSEC:0001104659-26-024760:0
31,246 shares0Common StockSEC:0001104659-26-024759:0
52,087 shares0Common StockSEC:0001104659-26-023539:0
12,307 shares0Common StockSEC:0001104659-26-023538:0
5,470 shares0Common StockSEC:0001104659-26-023537:0
12,697 shares0Common StockSEC:0001104659-26-023535:0
120,000 shares0Common StockSEC:0001104659-26-020613:0
25 of 114 declarations
Acerca de Iovance Biotherapeutics, INC.
Iovance Biotherapeutics, INC. es una empresa biofarmacéutica centrada en el desarrollo de terapias celulares para el tratamiento del cáncer. Se especializa en el uso de células T modificadas para atacar y destruir células tumorales.